Cargando…
Antibiotic drug discovery
Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous develop...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993170/ https://www.ncbi.nlm.nih.gov/pubmed/27470984 http://dx.doi.org/10.1111/1751-7915.12388 |
_version_ | 1782449118105305088 |
---|---|
author | Wohlleben, Wolfgang Mast, Yvonne Stegmann, Evi Ziemert, Nadine |
author_facet | Wohlleben, Wolfgang Mast, Yvonne Stegmann, Evi Ziemert, Nadine |
author_sort | Wohlleben, Wolfgang |
collection | PubMed |
description | Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous development over the past few years. This has been the consequence of several new and revolutionizing drug discovery and development techniques, which is initiating a ‘New Age of Antibiotic Discovery’. In this review, we concentrate on the most significant discovery approaches during the last and present years and comment on the challenges facing the community in the coming years. |
format | Online Article Text |
id | pubmed-4993170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49931702016-08-31 Antibiotic drug discovery Wohlleben, Wolfgang Mast, Yvonne Stegmann, Evi Ziemert, Nadine Microb Biotechnol Special Issue Articles Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous development over the past few years. This has been the consequence of several new and revolutionizing drug discovery and development techniques, which is initiating a ‘New Age of Antibiotic Discovery’. In this review, we concentrate on the most significant discovery approaches during the last and present years and comment on the challenges facing the community in the coming years. John Wiley and Sons Inc. 2016-07-29 /pmc/articles/PMC4993170/ /pubmed/27470984 http://dx.doi.org/10.1111/1751-7915.12388 Text en © 2016 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Issue Articles Wohlleben, Wolfgang Mast, Yvonne Stegmann, Evi Ziemert, Nadine Antibiotic drug discovery |
title | Antibiotic drug discovery |
title_full | Antibiotic drug discovery |
title_fullStr | Antibiotic drug discovery |
title_full_unstemmed | Antibiotic drug discovery |
title_short | Antibiotic drug discovery |
title_sort | antibiotic drug discovery |
topic | Special Issue Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993170/ https://www.ncbi.nlm.nih.gov/pubmed/27470984 http://dx.doi.org/10.1111/1751-7915.12388 |
work_keys_str_mv | AT wohllebenwolfgang antibioticdrugdiscovery AT mastyvonne antibioticdrugdiscovery AT stegmannevi antibioticdrugdiscovery AT ziemertnadine antibioticdrugdiscovery |